11.57 am | 09 Feb 2012 |  Source: CNBC-TV18

Biocon has target of Rs 296, says Amit Gupta, Head-Derivatives -ICICI Direct....

11.28 am | 06 Feb 2012 |  Source: CNBC-TV18

Enter Biocon, says Hemant Thukral, National Head-Derivative Desk, Aditya Birla Money....

9.17 am | 06 Feb 2012 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Biocon....

8.36 am | 06 Feb 2012 |  Source: CNBC-TV18

On CNBC-TV18's new show Super Six, market gurus Hemen Kapadia of chartpundit.com, Nooresh Merani of AMSEC Research and Arunesh Madan, Founder and Dire...

8.28 am | 06 Feb 2012 |  Source: CNBC-TV18

The market closed last week with a flourish. The Nifty ended above the 5,300 mark. Sudarshan Sukhani, s2analytics.com says, the market has rallied dec...

3.38 pm | 01 Feb 2012 |  Source: Moneycontrol.com

Sushil Finance is bullish on Biocon and has recommended buy rating on the stock with a target price of Rs 325 in its January 30, 2012 research report....

11.22 am | 31 Jan 2012 |  Source: Moneycontrol.com

Unicon Investment is bullish on Biocon and has recommended buy rating on the stock with a target of Rs 320 in its January 30, 2012 research report....

1.54 pm | 30 Jan 2012 |  Source: Moneycontrol.com

Dolat Capital is bullish on Biocon and has recommended buy rating on the stock with a target of Rs 373 in its January 25, 2012 research report....

11.58 am | 27 Jan 2012 |  Source: Moneycontrol.com

Biocon has reported a sales turnover of Rs 386.12 crore and a net profit of Rs 64.73 crore for the quarter ended Dec '11...

11.02 am | 25 Jan 2012 |  Source: Reuters

Biocon, India's top-listed biotechnology company, expects to generate larger licensing income from pharmaceuticals business, its Chairman and Managing...

9.13 am | 24 Jan 2012 |  Source: CNBC-TV18

Pharmaceutical firm Biocon is likely to post a profit after tax of Rs 94 crore in the third quarter of FY12, a growth of 10% as compared to Rs 86 cror...

11.50 am | 18 Jan 2012 |  Source: Moneycontrol.com

IIFL is bullish on Biocon and has recommended buy rating on the stock with a target of Rs 276 in its January 18, 2012 research report....

9.13 am | 18 Jan 2012 |  Source: CNBC-TV18

Sudarshan Sukhani, s2analytics.com feels that there is more upside in Idea....

8.58 am | 18 Jan 2012 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analystics spoke to CNBC-TV18 about where the market is likely to go today and what are the best ways to play the rally....

9.09 am | 13 Jan 2012 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com one can short Biocon....

8.22 am | 13 Jan 2012 |  Source: CNBC-TV18

Sudarshan Sukhani, s2analytics.com says, the short term-trend is still up. “Trader can take long positions,” he advises....

8.40 am | 09 Jan 2012 |  Source: Moneycontrol.com

ICICIdirect.com has come out with its report on Nifty Future, Bank of India (BOI), Polaris Software, Biocon and IDFC...

4.07 pm | 07 Dec 2011 |  Source: Moneycontrol.com

GEPL Capital has come out with its report on top trading picks. The research firm recommends buying Ashok Leyland, Jubilant Food and selling Biocon....

3.32 pm | 01 Dec 2011 |  Source: Moneycontrol.com

Dolat Capital is bullish on Biocon and has recommended buy rating on the stock with a target of Rs 421 in its December 1, 2011 research report....

1.43 pm | 16 Nov 2011 |  Source: Moneycontrol.com

According to IIFL, traders can sell Biocon November future below Rs 325 with stop loss of Rs 331 for target of Rs 313, in its November 16, 2011 resear...